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Abstract 
Cartilage oligomeric matrix protein is a structural protein of the extracellular matrix, while 
thrombospondin-2 is a matricellular protein involved in cell–matrix interactions. Recent studies have 
shown that genetic variation is a signiﬁcant risk factor for Achilles tendinopathy, and the genes 
encoding cartilage oligomeric matrix protein (COMP) and thrombospondin-2 (THBS2) were 
identiﬁed as good candidate genes for association with Achilles tendinopathy. This study aimed to test 
the association of sequence variants within these candidate genes with the risk of Achilles tendinopathy in 
participants from South Africa (SA) and Australia (AUS). Three-hundred and forty (133 SA; 207 
AUS) control participants with no history of Achilles tendinopathy and 178 (94 SA; 84 AUS) 
participants clinically diagnosed with Achilles tendinopathy were genotyped for ﬁve single nucleotide 
polymorphisms within the COMP and THBS2 genes in this case-control study. There was no 
difference in genotype distributions between control and tendinopathy groups for either the 
THBS2 variants rs9505888, rs6422747 and rs9283850, or the COMP variants rs730079 and 
rs28494505 in the SA and AUS populations. As the selection of COMP and THBS2 as candidate 
genes was hypothesis driven, based on biological function, the possibility that other variants within 
these genes are associated with Achilles tendinopathy cannot be excluded. 
 
Introduction 
The Achilles tendon is exposed to high mechanical forces during exercise and is often 
a site of overuse injuries in athletes and the general population (de Jonge et al., 2011; 
Jarvinen et al., 2001). Achilles tendinopathy is a clinical syndrome comprising of 
swelling in and around the tendon, tenderness to palpation and pain-induced 
impairment of physical performance (Jarvinen et al., 2001; Maffulli, Khan, & Puddu, 
1998; Rees, Dent, & Caterson, 2009; Xu & Murrell, 2008). Achilles tendinopathy 
encompasses a range of more speciﬁc diagnoses, which includes, amongst others, 
tendinosis, a condition characterised by chronic degeneration of the tendon without 
histological signs of inﬂammation.(Jarvinen et  al.,  1997;  Khan,  Cook,  Kannus,  
Maffulli,  & Bonar, 2002). The cumulative lifetime incidence of Achilles tendinopathy 
in former elite athletes has been estimated at 23.9%, and is as high as 52% in middle 
and long distance runners (Kujala, Sarna, & Kaprio, 2005). Although the pathology 
of Achilles tendinopathy has been well characterised with clearly documented clinical 
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and imaging diagnostic criteria (Del Buono, Chan, & Maffulli, 2013; Jarvinen et al., 
1997; Kader, Saxena, Movin, & Maffulli, 2002), the exact aetiology of the condition 
remains undeﬁned. Several extrinsic and intrinsic risk factors for developing Achilles 
tendinopathy have been proposed, including a signiﬁcant heritable component 
(Collins & Raleigh, 2009; Kannus, 1997; Kannus & Natri, 1997; September, Mokone, 
Schwellnus, & Collins, 2006).  To date, polymorphisms in several genes coding for 
structural and associated proteins of the extracellular matrix have been investigated 
as candidate genes for the risk of developing Achilles tendinopathy. In particular, 
sequence variants within the   COL5A1,   TNC,   GDF-5,   MMP3,   CASP8 and 
COL27A1 genes, as well as the interleukin genes IL-1β, IL-1RN and IL-6, have been 
shown to inﬂuence  an  individual’s  susceptibility  to  Achilles tendinopathy (Mokone 
et al., 2005; Mokone, Schwellnus, Noakes, & Collins, 2006; Nell et al., 2012; 
Posthumus et al., 2010; Raleigh et al., 2009; Saunders et al., 2013; September et 
al., 2009; September et al., 2011). 
 
In this study we investigated two further candidate genes, THBS2 and COMP, which 
code for thrombospondin-2 and cartilage oligomeric matrix protein 
(thrombospondin-5) respectively. All thrombospondins contain a highly conserved 
signature protein domain at the carboxy terminal and a number of disease 
associated genetic variants have been mapped to this domain (Carlson, Lawler, & 
Mosher, 2008). Thrombospondin-2, in particular, is involved in the healing 
response in connective tissues and plays a signiﬁcant role in cell–matrix 
interactions (Adams & Lawler, 2004; Bornstein, Agah, & Kyriakides, 2004; 
Bornstein, Armstrong, Hankenson, Kyriakides, & Yang, 2000). Two single 
nucleotide polymorphisms (SNPs) within the THBS2 gene (chr6q27), rs9283850 
(Intron 9) and rs6422747 (Intron 14), have previously been implicated in a 
haplotype associated with lumbar disc herniation in a Japanese population 
(Hirose et al., 2008). Cartilage oligomeric matrix protein interacts with type I and 
type III collagens and plays an important role in matrix assembly and the repair 
of injured tissues (Hecht, Hayes, Haynes, & Cole, 2005; Posey, Yang, Veerisetty, 
Sharan, & Hecht, 2008; Rosenberg, Olsson, Morgelin, & Heinegard, 1998; 
Sodersten, Hultenby, Heinegard, Johnston, & Ekman, 2013).  Genetic variants 
clustered  in the conserved calcium binding domains and carboxy terminal of the 
cartilage oligomeric matrix protein have been repeatedly associated with skeletal 
dysplasias (Adams & Lawler, 2004; Hecht et al., 2005; Ikegawa et al., 1998) and 
other cartilage disorders including osteoarthritis of the knee (Valdes et al., 2007). 
The C-allele of the rs730079 (-1417C>G) SNP within the 5’-UTR of the COMP 
gene (chr19p13.11) was previously associated with osteoarthritis in a Caucasian 
male population (Valdes et al., 2007), while the rs28494505 (Intron 18) Tag SNP is 
located within the highly conserved C-terminal domain of the Cartilage oligomeric 
matrix protein. These observations, together with the biological roles of these 
proteins, suggest that both COMP and THSB2 are good candidate genes for 
association with risk of developing Achilles tendinopathy. The aim of this study was, 
http://repository.uwc.ac.za
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therefore, to test the association of sequence variants within the COMP, rs730079 
(C>G) and rs28494505 (A>G), and THBS2, rs9283850 (A>G), rs6422747 (A>G) 
and rs9505888 (A>G), candidate genes with the risk of Achilles tendinopathy in 
participants from South Africa and Australia. 
 
Methods 
As previously described, 133 South African asymptomatic control participants (SA 
CON)  and  94 South African participants clinically diagnosed with AT (SA TEN), as 
well as 207 Australian asymptomatic control participants (AUS CON) and 84 
Australian participants clinically diagnosed with AT (AUS TEN) were recruited for 
this study (Mokone et al., 2005; September et al., 2009). In particular, tendinopathy 
participants were diagnosed with chronic, degenerative tendinosis without signs of 
inﬂammation. The presence of gradual progressive pain over the posterior lower leg 
for more than six months, together with at least one of the following clinical criteria, 
was used to diagnose chronic Achilles   tendinopathy:   (i)   early   morning   pain; (ii) 
early morning stiffness; (iii) history of swelling over the Achilles tendon area; (iv) 
tenderness to palpation; (v) palpable nodular thickening over the affected Achilles; 
and/or (vi) a positive shift test during plantar-/dorsi-ﬂexion (Kader et al., 2002; 
Schepsis, Jones, &  Haas, 2002). The diagnosis of each tendinopathy participant was 
reviewed by the same clinician in SA and AUS, and was conﬁrmed using soft tissue 
ultrasound in a sub-group of SA participants and all the AUS participants. Control 
participants were physically active and asymptomatic with no history of Achilles tendon 
injury. Individuals with a self-reported history of treatment with either 
ﬂuoroquinolone antibiotics or local corticosteroid injections, as well as those who had 
previously suffered, or were currently suffering from any connective tissue disorders 
or other systemic diseases associated with Achilles tendinopathy were excluded from 
the study. All participants were of self-reported Caucasian ancestry, gave written 
informed consent in accordance with the Declaration of Helsinki and completed a 
questionnaire providing personal particulars and medical history. This study was 
approved by the Human Research Ethics Committee of the Faculty of Health Sciences, 
University of Cape Town and the Human Ethics Committee of La Trobe and Monash 
Universities, Melbourne, Australia. 
 
The three THBS2 SNPs rs9283850 (A>G), rs6422747 (A>G) and rs9505888 
(A>G) and the two  COMP  SNPs,  rs730079  (-1417C>G)  and rs28494505  (A>G),  
were  selected  based  on  their linkage, heterozygosity score (>35%), minor allele frequency 
(>20%) and previous association with other clinical phenotypes (Figures 1 and 2) (Hirose et 
al., 2008; Valdes et al., 2007). The rs9505888 SNP was selected based on its linkage to 
rs6422747. In addition, all three THBS2 SNPs are identiﬁed as Tag SNPs 
(http://gvs.gs.washington. edu/GVS137) and therefore provide moderate coverage of this 38.3kb 
gene. The rs28494505 variant was selected based on its location within the highly conserved C-
terminal domain of the cartilage oligomeric matrix protein and its identiﬁcation as a Tag SNP. 
 
http://repository.uwc.ac.za
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DNA for all South African (227) and Australian (291) participants was isolated from venous 
blood as described by Lahiri and Nurnberger (1991) and modiﬁed by Mokone et al. 
(2005). Variants rs9505888, rs6422747 and rs28494505 were genotyped using standard 
polymerase chain reaction (PCR) and restriction fragment length polymorphism techniques 
(PCR conditions detailed in supplementary material). PCR reactions were performed on a 
thermal cycler (Hybaid: PCR Express, Middlesex, UK) with the resulting amplicon 
incubated with the BstUI, MfeI and MspI nucleases respectively. Restriction fragments 
were resolved, together with a 100bp size standard, by 6% polyacrylamide gel electrophoresis 
and visualised under UV light after staining with SYBR Gold nucleic acid gel stain 
(Invitrogen). Variants rs9283850 and rs730079, as well as a subset of samples for 
rs28494505, were genotyped using TaqMan SNP Genotyping Assays (Applied Biosystems) 
that were ampliﬁed and distinguished using the StepOnePlus Real-Time PCR System (Applied 
Biosystems). For quality control purposes, a number of positive and DNA-free controls were 
included in all PCR reactions, and a small subset of samples was analysed for repeatability within 
each variant. 
 
The programming environment R (R Development Core Team, 2010), and R package, genetics 
(Warnes, Gorjanc, Leisch, & others, 2011), was used for all statistical analyses. Age, sex, 
country grouping and country of birth were considered potential confounders, and so 
were corrected for in the logistic regression models of genotype and allele association with 
http://repository.uwc.ac.za
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Achilles tendinopathy, as well as in the linear models of the association of genotype and allele 
frequencies with physical characteristics of the participants. 
 
Results 
Basic characteristics of the study groups were presented previously and are included in 
(Mokone et al., 2005; September et al., 2009). Tendinopathy participants were signiﬁcantly 
heavier than the control participants at the time of recruitment (P<0.001); however, this 
difference was much less pronounced after adjusting for country grouping, sex and age 
(P=0.044). Genotype and minor allele frequency distributions for each of the polymorphisms, 
together with Hardy-Weinberg Equilibrium (HWE) p-values, are shown in Table II. The 
frequency distributions of the SNPs tested in this study were found to differ signiﬁcantly 
between the South African and Australian participant groups at the rs28494505 (P<0.001) and 
rs6422747 loci (P=0.024) (Table II). 
 
Table I 
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The two populations were therefore summarised separately. All genotype distributions were 
in HWE except at the rs28494505 locus that deviated signiﬁcantly in the AUS control group 
(P=0.043). It was, however, noted that a lower genotype call rate was observed for this variant in 
the AUS samples. There were no signiﬁcant genotype effects on age, weight, height, BMI or sex after 
adjusting for possible confounders (Table III). After adjusting for the potential confounder’s age, 
sex, country grouping and country of birth, there were no signiﬁcant differences in either the 
genotype or allele frequency distributions between the control and tendinopathy groups. 
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Discussion 
The primary ﬁnding of this study is that there was no association of the selected genetic variants within the 
COMP and THBS2 candidate genes with Achilles tendinopathy in the two populations studied. This study 
was only sufﬁciently powered to detect large effects on risk of developing Achilles tendinopathy (odds 
ratio (OR) >2) (Gauderman, 2002), and was therefore unlikely to detect any risk variant with a small 
effect. However, it should be noted that there was no tendency towards association with Achilles 
tendinopathy for any of the variants investigated. Although we cannot exclude the possibility that other 
variants within these genes are associated with Achilles tendinopathy, all the SNPs investigated in this study 
were identiﬁed as Tag SNPs and it is, therefore, unlikely that any SNPs tightly linked to these would show a 
signiﬁcant effect on risk of Achilles tendinopathy. Both THBS2 (38,3kb) and COMP (8,5kb) are 
small genes and the Tag SNPs selected span 11,6kb and 9,9kb respectively, therefore giving moderate 
coverage of both genes. However, it still remains possible that other rare or common sequence 
variants within COMP and THBS2 may be associated with the risk of Achilles tendinopathy. 
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Previous work in this area has shown that genetic variants in genes encoding structural components of 
the collagen ﬁbril often have large effects on risk of developing Achilles tendinopathy (OR>2) 
(Mokone et al., 2005; Mokone et al., 2006; Raleigh et al., 2009). Furthermore, rare mutations 
within genes encoding these structural components cause a range of severe disorders of connective 
tissue including pseudoachondroplasia, multiple epiphyseal dysplasia, osteogenesis imperfecta and 
Ehlers-Danlos syndrome (Hecht et al., 2005; Ikegawa et al., 1998; Malfait et al., 2005; Michalickova, 
Susic, Willing, Wenstrup, & Cole, 1998; Pollitt et al., 2006; Smith, Schwarze, Goldstein, & Byers, 
1997). Based on these observations it has been suggested that there is limited redundancy within 
the biological mechanisms leading to collagen ﬁbrillogenesis, and that common variants in the 
associated genes may have large effects on the risk of developing mild connective tissue pathology, 
such as Achilles tendinopathy (Ribbans & Collins, 2013). 
 
The thrombospondins are calcium binding glycoproteins that can be divided into two subfamilies 
with distinct biological roles (Adams & Lawler, 2004; Bornstein et al., 2004). However, the 
carboxy terminal signature domain of all thrombospondins, which contains the EGF-like repeats, 
type III calcium binding repeats and a carboxy terminal lectin-like globule, is highly conserved 
between the ﬁve members of this protein family (Adams & Lawler, 2004; Carlson et al., 2008). 
Thrombospondin-1 and thrombospondin-2 are matricellular proteins that form homotrimers and 
modulate cell functions and cell–matrix interactions (Bornstein et al., 2004), while 
thrombospondin-3,-4 and -5 are structural proteins of the extracellular matrix and form 
homopentamers (Adams & Lawler, 2004; Bornstein et al., 2000; Bornstein et al., 2004). 
Investigation of thrombospondin-2 null mice has implicated this protein in the regulation of collagen 
ﬁbrillogenesis and ﬁbril diameter, possibly through its regulation of ambient matrix 
metalloproteinase-2 levels (Bornstein et al., 2000; Bornstein et al., 2004; Kyriakides et al., 
1998). Cartilage oligomeric matrix protein is expressed in bovine and equine tendons, particularly in 
growing tendons and in response to mechanical load (DiCesare, Hauser, Lehman, Pasumarti, & 
Paulsson, 1994; Smith, Birch, Goodman, Heinegard, & Goodship, 2002; Smith, Zunino, 
Webbon, & Heinegard,  1997). Recent investigation has identiﬁed a mechano-responsive element 
in the 3kb proximal promoter of the human COMP gene (Amanatullah et al., 2012). In 
numerous studies of equine tendons, Smith et al. (Smith, Birch, et al., 2002; Smith, Gerard, et al., 
2002; Smith, Zunino et al., 1997) have shown that cartilage oligomeric matrix protein levels are 
correlated to ultimate tensile stress and stiffness of tendon tissue and suggest that the appropriate 
expression of cartilage oligomeric matrix protein is necessary for the formation of a functional ECM 
http://repository.uwc.ac.za
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and the structural integrity of tendons. Additionally, serum cartilage oligomeric matrix protein has 
been inversely associated with joint hypermobility (Chen et al., 2008), a  risk factor for  Achilles 
tendinopathy (Collins, Mokone, September, van der Merwe, & Schwellnus, 2009). There is also 
evidence to suggest that variations within the signature domain of the COMP gene alter protein 
structure and folding, and disrupt calcium binding (Chen, Deere, Hecht, & Lawler, 2000; Hecht et 
al., 2005; Hou, Putkey, & Hecht, 2000; Kvansakul, Adams, & Hohenester, 2004; Maddox, 
Mokashi, Keene, & Bachinger, 2000). It is therefore possible that sequence variants that have even a 
minor effect on transcription, translation or protein structure and function will result in at least a mild 
inherited clinical dysplasia. Taking into account the high sequence conservation of both the 
COMP and THBS2 genes between species, it remains possible that rare sequence variants (minor   
allele   frequency   0.1–3.0%)   within   these genes might be associated with a large 
effect on the risk of Achilles tendinopathy (Bodmer & Bonilla, 2008; Ovcharenko, 
Nobrega, Loots, &  Stubbs, 2004). Such rare variants often have a larger effect on risk 
as well as greater penetrance, making them good targets for prophylactic treatments 
(Bodmer & Bonilla, 2008). For example, the rare TT genotype (<5% in Caucasian 
populations) of the functional Sp1-binding site polymorphism (rs1800012; G>T) within 
intron 1 of the COL1A1 gene is associated with reduced risk of acute soft tissue 
ruptures (Collins, Posthumus, & Schwellnus, 2009; Khoschnau et al., 2008; 
Posthumus et al., 2009). Associations of common  multifactorial  diseases with rare 
variants are unlikely to be found by either genome-wide association studies or case-
control association studies such as the current study, and further work would therefore 
be necessary  to  test this hypothesis (Bodmer & Bonilla, 2008). 
 
Strengths and limitations 
A limitation to this study is that the tendinopathy participants were signiﬁcantly 
heavier than the control participants at the time of recruitment. Although the 
tendinopathy participant’s weight at the time of injury was not determined, several 
participants reported an increase in weight after injury due to inactivity. In addition, 
this difference may be explained by the higher proportion of males in the 
tendinopathy groups as the difference was much less pronounced after adjusting for 
country, sex and age. Another limitation is that, due to a low sample size, this study 
was only sufﬁciently powered to detect large effects on risk of AT (OR>2.0). The 
strength of this study lays in the hypothesis-driven selection of the candidate genes and 
variants investigated, and the stringent selection of homogenous tendinopathy 
participants. 
 
Conclusions 
In conclusion, this study did not identify an association between the common 
sequence variants investigated and increased risk of Achilles tendinopathy. 
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